The results of multicenter treatment of atypical teratoid/rhabdoid tumors of the central nervous system in children under 3 years

Cover Page
  • Authors: Olkhova L.V.1, Zheludkova O.G.2, Zubarovskaya L.S.3, Smirnova A.Y.4, Dinikina Y.V.4,5, Kushel Y.V.6, Melikyan A.G.6, Gorelyshev S.K.6, Ryzhova M.V.6, Trunin Y.Y.6, Shults E.I.6, Gevorgyan A.G.3, Gorbatykh S.V.7, Kislyakov A.N.7, Popov V.E.8, Privalova L.P.9, Yudina N.B.10, Tarasova E.M.1, Pogorelov D.N.11, Polushkina O.B.2, Levashov A.S.12, Vorobyov N.A.13,14,15, Plakhotina N.A.13, Martynova N.I.13, Skvortsova T.Y.16, Zaychikov A.N.17, Mushinskaya M.V.18, Sakun D.L.19, Minkina L.M.20, Lukina T.V.21, Shchepkina E.V.22, Korshunov A.G.23
  • Affiliations:
    1. Russian Children's Clinical Hospital of the N.I. Pirogov Russian National Research Medical University of Ministry of Healthcare of the Russian Federation
    2. V.F. Voino-Yasenetskiy Scientific and Practical Center of Specialized Healthсare for Children of the Department of Health of Moscow
    3. R.M. Gorbacheva Research Institute for Pediatric Oncology, Hematology and Transplantation, I.P. Pavlov First Saint Petersburg State Medical University, Ministry of Healthcare of the Russian Federation
    4. V.A. Almazov National Medical Research Centre of Ministry of Healthcare of the Russian Federation
    5. Saint Petersburg State Pediatric Medical University of Ministry of Healthcare of the Russian Federation
    6. N.N. Burdenko National Medical Research Center of Neurosurgery of Ministry of Healthcare of the Russian Federation
    7. Morozov Children's City Clinical Hospital of the Department of Health of Moscow
    8. M.F. Vladimirsky Moscow Regional Research Clinical Institute
    9. Nizhny Novgorod Regional Children's Hospital
    10. Voronezh Regional Children's Clinical Hospital No. 1
    11. Regional Children's Hospital of Ministry of Healthcare of the Russian Federation, Lipetsk
    12. N.N. Blokhin National Medical Research Center of Oncology of Ministry of Healthcare of the Russian Federation
    13. Diagnostic and Treatment Center of the Sergey Berezin International Institute of Biological Systems
    14. Saint Petersburg State University
    15. I.I. Mechnikov North-Western State Medical University of Ministry of Healthcare of the Russian Federation
    16. N.P. Bekhtereva Institute of the Human Brain, Russian Academy of Sciences
    17. Regional Children's Clinical Hospital No.1, Yekaterinburg
    18. F.P. Haass Center of Pediatric Oncology and Hematology, Regional Children's Clinical Hospital, Perm
    19. Republican Children's Clinical Hospital, Simferopol
    20. Regional Children's Clinical Hospital No. 1, Vladivostok
    21. Diagnostic and Treatment Center of the Sergey Berezin International Institute of Biological Systems, Saint Petersburg
    22. Techdepartament, Moscow Region, Khimki
    23. German Cancer Research Center (DKFZ)
  • Issue: Vol 20, No 2 (2021)
  • Pages: 121-132
  • Section: ORIGINAL ARTICLES
  • Submitted: 21.05.2021
  • Accepted: 21.05.2021
  • Published: 18.06.2021
  • URL: https://hemoncim.com/jour/article/view/515
  • DOI: https://doi.org/10.24287/1726-1708-2021-20-2-121-132
  • ID: 515

Cite item

Full Text

Abstract

Atypical teratoid/rhabdoid tumor (AT/RT) of the central nervous system (CNS) is an aggressive malignant tumor that is mainly found in younger children and is associated with poor prognosis. Our objectives: to present the results of treatment of children with CNS AT/RT under 3 years of age and assess the impact of various prognostic factors on patient survival. The study was approved by the Independent Ethics Committee and the Scientific Council of the N.I. Pirogov Russian National Research Medical University of Ministry of Healthcare of the Russian Federation. The study included 106 patients with CNS AT/RT aged 0–3 years who had been treated and monitored from 2008 to 2020. The median age was 16 (9; 23) months. All the patients underwent primary tumor resection with subsequent chemotherapy according to various protocols. At the time of the analysis, 47 patients (44.4%) were alive, 1 patient (0.9%) was lost to follow-up and 58 patients (54.7%) were dead, of whom 52 patients (90%) had died of disease progression and 6 (10%) – of polychemotherapy complications. One patient developed shunt-related intraabdominal metastasis within 10 months of the diagnosis. The 1-year progression-free survival (PFS) was 0.50; the 2-year PFS was 0.29; the 5-year PFS – 0.27. The median PFS was 12 months. The 1-year overall survival (OS) was 0.72; the 2-year OS was 0.53; the 5-year OS – 0.40. The median OS was 27 months. An analysis of patients with CNS AT/RT under 3 years of age showed that PFS was statistically significantly higher in: children aged > 12 months; children with totally resected tumours; children who had received polychemotherapy in accordance with the ATRT-2006 protocol that included radiotherapy and regional administration of a triplet of chemotherapeutic agents. The OS in patients with CNS AT/RT aged < 3 years was statistically significantly higher in: children aged > 12 months; children who had been treated with radiation therapy; patients who had received cytosar/etoposide intrathecally/intraventricularly; patients who had undergone high-dose chemotherapy with subsequent autologous hematopoietic stem cell transplantation. A multivariate analysis revealed that PFS was influenced by age, tumor location, extent of resection and exposure to radiation therapy, regional chemotherapy or high-dose chemotherapy with autologous hematopoietic stem cell transplantation, while OS was affected by age and exposure to radiation therapy.

About the authors

L. V. Olkhova

Russian Children's Clinical Hospital of the N.I. Pirogov Russian National Research Medical University of Ministry of Healthcare of the Russian Federation

Author for correspondence.
Email: rylkova87@mail.ru

Lyudmila V. Olkhova, a pediatric oncologist at the Department 
of Bone Marrow Transplantation 

117 Leninskiy Prosp, Moscow 117997

Russian Federation

O. G. Zheludkova

V.F. Voino-Yasenetskiy Scientific and Practical Center of Specialized Healthсare for Children of the Department of Health of Moscow

Russian Federation

L. S. Zubarovskaya

R.M. Gorbacheva Research Institute for Pediatric Oncology, Hematology and Transplantation, I.P. Pavlov First Saint Petersburg State Medical University, Ministry of Healthcare of the Russian Federation

Russian Federation

A. Yu. Smirnova

V.A. Almazov National Medical Research Centre of Ministry of Healthcare of the Russian Federation

Russian Federation

Yu. V. Dinikina

V.A. Almazov National Medical Research Centre of Ministry of Healthcare of the Russian Federation; Saint Petersburg State Pediatric Medical University of Ministry of Healthcare of the Russian Federation

Russian Federation

Yu. V. Kushel

N.N. Burdenko National Medical Research Center of Neurosurgery of Ministry of Healthcare of the Russian Federation

Russian Federation

A. G. Melikyan

N.N. Burdenko National Medical Research Center of Neurosurgery of Ministry of Healthcare of the Russian Federation

Russian Federation

S. K. Gorelyshev

N.N. Burdenko National Medical Research Center of Neurosurgery of Ministry of Healthcare of the Russian Federation

Russian Federation

M. V. Ryzhova

N.N. Burdenko National Medical Research Center of Neurosurgery of Ministry of Healthcare of the Russian Federation

Russian Federation

Yu. Yu. Trunin

N.N. Burdenko National Medical Research Center of Neurosurgery of Ministry of Healthcare of the Russian Federation

Russian Federation

E. I. Shults

N.N. Burdenko National Medical Research Center of Neurosurgery of Ministry of Healthcare of the Russian Federation

Russian Federation

A. G. Gevorgyan

R.M. Gorbacheva Research Institute for Pediatric Oncology, Hematology and Transplantation, I.P. Pavlov First Saint Petersburg State Medical University, Ministry of Healthcare of the Russian Federation

Russian Federation

S. V. Gorbatykh

Morozov Children's City Clinical Hospital of the Department of Health of Moscow

Russian Federation

A. N. Kislyakov

Morozov Children's City Clinical Hospital of the Department of Health of Moscow

Russian Federation

V. E. Popov

M.F. Vladimirsky Moscow Regional Research Clinical Institute

Russian Federation

L. P. Privalova

Nizhny Novgorod Regional Children's Hospital

Russian Federation

N. B. Yudina

Voronezh Regional Children's Clinical Hospital No. 1

Russian Federation

E. M. Tarasova

Russian Children's Clinical Hospital of the N.I. Pirogov Russian National Research Medical University of Ministry of Healthcare of the Russian Federation

 Е.М. Тарасова

Russian Federation

D. N. Pogorelov

Regional Children's Hospital of Ministry of Healthcare of the Russian Federation, Lipetsk

Russian Federation

O. B. Polushkina

V.F. Voino-Yasenetskiy Scientific and Practical Center of Specialized Healthсare for Children of the Department of Health of Moscow

Russian Federation

A. S. Levashov

N.N. Blokhin National Medical Research Center of Oncology of Ministry of Healthcare of the Russian Federation

Russian Federation

N. A. Vorobyov

Diagnostic and Treatment Center of the Sergey Berezin International Institute of Biological Systems; Saint Petersburg State University; I.I. Mechnikov North-Western State Medical University of Ministry of Healthcare of the Russian Federation

Russian Federation

N. A. Plakhotina

Diagnostic and Treatment Center of the Sergey Berezin International Institute of Biological Systems

Russian Federation

N. I. Martynova

Diagnostic and Treatment Center of the Sergey Berezin International Institute of Biological Systems

Russian Federation

T. Yu. Skvortsova

N.P. Bekhtereva Institute of the Human Brain, Russian Academy of Sciences

Russian Federation

A. N. Zaychikov

Regional Children's Clinical Hospital No.1, Yekaterinburg

Russian Federation

M. V. Mushinskaya

F.P. Haass Center of Pediatric Oncology and Hematology, Regional Children's Clinical Hospital, Perm

Russian Federation

D. L. Sakun

Republican Children's Clinical Hospital, Simferopol

Russian Federation

L. M. Minkina

Regional Children's Clinical Hospital No. 1, Vladivostok

Russian Federation

T. V. Lukina

Diagnostic and Treatment Center of the Sergey Berezin International Institute of Biological Systems, Saint Petersburg

Russian Federation

E. V. Shchepkina

Techdepartament, Moscow Region, Khimki

Russian Federation

A. G. Korshunov

German Cancer Research Center (DKFZ)

Germany

References

  1. Hilden J.M., Meerbaum S., Burger P., Finlay J., Janss A., Scheithauer B.W., et al. Central nervous system atypical teratoid/rhabdoid tumor: results of therapy in children enrolled in a registry. J Clin Oncol 2004; 22 (14): 2877–84. doi: 10.1200/JCO.2004.07.073. PMID: 15254056.
  2. Tekautz T.M., Fuller C.E., Blaney S., Fouladi M., Broniscer A., Merchant T.E., et al. Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy. J Clin Oncol 2005; 23 (7): 1491–9. doi: 10.1200/JCO.2005.05.187. PMID: 15735125.
  3. Ostrom Q.T., Chen Y., de Blank P.M., Ondracek A., Farah P., Gittleman H., et al. The descriptive epidemiology of atypical teratoid/rhabdoid tumors in the United States, 2001–2010. Neuro Oncol 2014; 16 (10): 1392–9.
  4. Lau C.S., Mahendraraj K., Chamberlain R.S. Atypical teratoid rhabdoid tumors: a population-based clinical outcomes study involving 174 patients from the Surveillance, Epidemiology, and End Results database (1973–2010). Cancer Manag Res 2015; 7: 301–9.
  5. Желудкова О.Г., Коршунов А.Г., Горбатых С.В., Лившиц М.И., Попов В.Е., Тара-сова И.С. и др. Злокачественные тератоид-рабдоидные опухоли центральной нервной системы у детей. Вопросы гематологии/онкологии и иммунопатологии в педиатрии 2003; 2 (3): 32−9.
  6. Bartelheim K., Nemes K., Seeringer A., Kerl K., Buechner J., Boos J., et al. Improved 6-year overall survival in AT/RT – results of the registry study Rhabdoid 2007. Cancer Med 2016; 5 (8): 1765–75. doi: 10.1002/cam4.741.
  7. Frühwald M.C., Hasselblatt M., Nemes K., Bens S., Steinbügl M., Johann P.D., et al. Age and DNA methylation subgroup as potential independent risk factors for treatment stratification in children with atypical teratoid/rhabdoid tumors. Neuro Oncol 2020; 22 (7): 1006–17. doi: 10.1093/neuonc/noz244. PMID: 31883020; PMCID: PMC7339901.
  8. Ольхова Л.В., Желудкова О.Г., Кушель Ю.В., Меликян А.Г., Горелы-шев С.К., Рыжова М.В. и др. Результаты мультицентрового исследования лечения атипичных тератоидно-рабдоидных опухолей центральной нервной системы у детей. Педиатрия. Журнал им. Г.Н. Сперанского 2020; 99 (4): 18–27.
  9. Richardson E.A., Ho B., Huang A. Atypical teratoid rhabdoid tumor: from tumors to therapies. J Korean Neurosurg Soc 2018; 61 (3): 302–11. doi: 10.3340/jkns.2018.0061.
  10. Chi S.N., Zimmerman M.A., Yao X., Cohen K.J., Burger P., Biegel J.A., et al. Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor. J Clin Oncol 2009; 27 (3): 385–9. doi: 10.1200/JCO.2008.18.7724. Epub 2008 Dec 8. PMID: 19064966; PMCID: PMC2645855.
  11. Reddy A.T., Strother D.R., Judkins A.R., Burger P.C., Pollack I.F., Krailo M.D., et al. Efficacy of High-Dose Chemotherapy and Three-Dimensional Conformal Radiation for Atypical Teratoid/Rhabdoid Tumor: A Report From the Children's Oncology Group Trial ACNS0333. J Clin Oncol 2020; 38 (11): 1175–85. doi: 10.1200/JCO.19.01776. Epub 2020 Feb 27. PMID: 32105509; PMCID: PMC7145589.
  12. Park M., Han J.W., Hahn S.M., Lee J.A., Kim J.Y., Shin S.H., et al. Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System in Children Under the Age of 3 Years. Cancer Res Treat 2020. doi: 10.4143/crt.2020.756. Epub ahead of print. PMID: 33138347.
  13. Yang W.C., Yen H.J., Liang M.L., Chen H.H., Lee Y.Y., Chang F.C., et al. Effect of early radiotherapy initiation and high-dose chemotherapy on the prognosis of pediatric atypical teratoid rhabdoid tumors in different age groups. J Neurooncol 2020; 147 (3): 619–31. doi: 10.1007/s11060-020-03456-1. Epub 2020 Mar 28. PMID: 32222933.
  14. Ольхова Л.В., Желудкова О.Г., Попов В.Е., Басалай Т.В., Кисляков А.Н., Скобеев Д.А., Ким Л.А. Шунт-ассоциированное интраабдоминальное метастазирование атипичной тератоид-рабдоидной опухоли головного мозга. Детская хирургия 2020; 24 (2): 108–16.
  15. Fossey M., Li H., Afzal S., Fossey M., Li H., Afzal S., et al. Atypical teratoid rhabdoid tumor in the first year of life: the Canadian ATRT registry experience and review of the literature. J Neurooncol 2017; 132 (1): 155–62.
  16. Lu V.M., Di L., Eichberg D.G., Luther E.M., Shah A.H., Daniels D.J., et al. Age of diagnosis clinically differentiates atypical teratoid/rhabdoid tumors diagnosed below age of 3 years: a database study. Childs Nerv Syst 2020. doi: 10.1007/s00381-020-04972-1. Epub ahead of print. PMID: 33236183.
  17. Yamasaki K., Kiyotani C., Terashima K., Watanabe Y., Kanamori M., Koga Y., et al. Clinical characteristics, treatment, and survival outcome in pediatric patients with atypical teratoid/rhabdoid tumors: a retrospective study by the Japan Children's Cancer Group. J Neurosurg Pediatr 2019:1–10. doi: 10.3171/2019.9.PEDS19367. Epub ahead of print. PMID: 31731266.
  18. Fonseca A., Al-Karmi S., Vasiljevic A., Dodghsun A., Sin Chan P., Lafay Cousin L., et al. Rare embrional brain tumors. In: Brain tumors in children. Springer; 2018. Pp. 302–309.
  19. McGovern S.L., Okcu M.F., Munsell M.F., Kumbalasseriyil N., Grosshans D.R., McAleer M.F. Outcomes and acute toxicities of proton therapy for pediatric atypical teratoid/rhabdoid tumor of the central nervous system. Int J Radiat Oncol Biol Phys 2014; 90 (5): 1143–52.
  20. Weber D.C., Ares C., Malyapa R., Albertini F., Calaminus G., Kliebsch U., et al. Tumor control and QoL outcomes of very young children with atypical teratoid/ rhabdoid tumor treated with focal only chemo-radiation therapy using pencil beam scanning proton therapy. J Neurooncol 2015; 121 (2): 389–97.
  21. Sung K.W., Lim D.H., Yi E.S., Choi Y.B., Lee J.W., Yoo K.H., et al. Tandem HighDose Chemotherapy and Autologous Stem Cell Transplantation for Atypical Teratoid/Rhabdoid Tumor. Cancer Res Treat 2016; 48 (4): 1408–19. doi: 10.4143/crt.2015.347. Epub 2016 Apr 1. PMID: 27034140; PMCID: PMC5080816.
  22. Lafay-Cousin L., Hawkins C., Carret A.S., Johnston D., Zelcer S., Wilson B., et al. Central nervous system atypical teratoid rhabdoid tumours: the Canadian Paediatric Brain Tumour Consortium experience. Eur J Cancer. 2012; 48 (3): 353–9. doi: 10.1016/j.ejca.2011.09.005. Epub 2011 Oct 22. PMID: 22023887.
  23. Slavc I., Chocholous M., Leiss U., Haberler C., Peyrl A., Azizi A.A., et al. Atypical teratoid rhabdoid tumor: improved longterm survival with an intensive multimodal therapy and delayed radiotherapy. The Medical University of Vienna Experience 1992–2012. Cancer Med 2014; 3 (1): 91–100. doi: 10.1002/cam4.161. Epub 2013 Dec 11. PMID: 24402832; PMCID: PMC3930393.
  24. Zaky W., Dhall G., Ji L., Haley K., Allen J., Atlas M., et al. Intensive induction chemotherapy followed by myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for young children newly-diagnosed with central nervous system atypical teratoid/rhabdoid tumors: the Head Start III experience. Pediatr Blood Cancer 2014; 61 (1): 95–101. doi: 10.1002/pbc.24648. Epub 2013 Aug 11. PMID: 23934933.
  25. Underiner R.M., Eltobgy M., Stanek J.R., Finlay J.L., AbdelBaki M.S. Meta-Analysis of Treatment Modalities in Metastatic Atypical Teratoid/Rhabdoid Tumors in Children. Pediatr Neurol 2020; 108: 106–12. doi: 10.1016/j.pediatrneurol.2020.03.003. Epub 2020 May 8. PMID: 32402552.
  26. Schrey D., Carceller Lechón F., Malietzis G., Moreno L., Dufour C., Chi S., et al. Multimodal therapy in children and adolescents with newly diagnosed atypical teratoid rhabdoid tumor: individual pooled data analysis and review of the literature. J Neurooncol 2016; 126 (1): 81–90. doi: 10.1007/s11060-015-1904-0. Epub 2015 Nov 25. PMID: 26608522.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2021 Olkhova L.V., Zheludkova O.G., Zubarovskaya L.S., Smirnova A.Y., Dinikina Y.V., Kushel Y.V., Melikyan A.G., Gorelyshev S.K., Ryzhova M.V., Trunin Y.Y., Shults E.I., Gevorgyan A.G., Gorbatykh S.V., Kislyakov A.N., Popov V.E., Privalova L.P., Yudina N.B., Tarasova E.M., Pogorelov D.N., Polushkina O.B., Levashov A.S., Vorobyov N.A., Plakhotina N.A., Martynova N.I., Skvortsova T.Y., Zaychikov A.N., Mushinskaya M.V., Sakun D.L., Minkina L.M., Lukina T.V., Shchepkina E.V., Korshunov A.G.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.